Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial
Ashina, Messoud, Lanteri-Minet, Michel, Pozo-Rosich, Patricia, Ettrup, Anders, Christoffersen, Cecilie Laurberg, Josiassen, Mette Krog, Phul, Ravinder, Sperling, Bjørn
Published in Lancet neurology (01.07.2022)
Published in Lancet neurology (01.07.2022)
Get full text
Journal Article
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study
Ashina, Messoud, Lanteri-Minet, Michel, Ettrup, Anders, Christoffersen, Cecilie Laurberg, Josiassen, Mette Krog, Phul, Ravinder, Sperling, Bjørn, Pozo-Rosich, Patricia
Published in Cephalalgia (01.05.2023)
Published in Cephalalgia (01.05.2023)
Get full text
Journal Article
Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures
Goadsby, Peter J., Barbanti, Piero, Lambru, Giorgio, Ettrup, Anders, Christoffersen, Cecilie Laurberg, Josiassen, Mette Krog, Phul, Ravinder, Sperling, Bjørn
Published in European journal of neurology (01.04.2023)
Published in European journal of neurology (01.04.2023)
Get full text
Journal Article
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial
Ashina, Messoud, Lipton, Richard B., Ailani, Jessica, Versijpt, Jan, Sacco, Simona, Mitsikostas, Dimos D., Christoffersen, Cecilie Laurberg, Sperling, Bjørn, Ettrup, Anders
Published in European journal of neurology (01.02.2024)
Published in European journal of neurology (01.02.2024)
Get full text
Journal Article
COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects
Hu, Xiao, Shang, Shulian, Nestorov, Ivan, Hasan, Jawad, Seddighzadeh, Ali, Dawson, Katherine, Sperling, Bjørn, Werneburg, Brian
Published in British journal of clinical pharmacology (01.08.2016)
Published in British journal of clinical pharmacology (01.08.2016)
Get full text
Journal Article
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
LaRocca, Nicholas G, Hudson, Lynn D, Rudick, Richard, Amtmann, Dagmar, Balcer, Laura, Benedict, Ralph, Bermel, Robert, Chang, Ih, Chiaravalloti, Nancy D, Chin, Peter, Cohen, Jeffrey A, Cutter, Gary R, Davis, Mat D, DeLuca, John, Feys, Peter, Francis, Gordon, Goldman, Myla D, Hartley, Emily, Kapoor, Raj, Lublin, Fred, Lundstrom, Gary, Matthews, Paul M, Mayo, Nancy, Meibach, Richard, Miller, Deborah M, Motl, Robert W, Mowry, Ellen M, Naismith, Rob, Neville, Jon, Panagoulias, Jennifer, Panzara, Michael, Phillips, Glenn, Robbins, Ann, Sidovar, Matthew F, Smith, Kathryn E, Sperling, Bjorn, Uitdehaag, Bernard MJ, Weaver, Jerry
Published in Multiple sclerosis (01.10.2018)
Published in Multiple sclerosis (01.10.2018)
Get full text
Journal Article
Relationship between Sustained Disability Progression and Functional System Scores in Relapsing-Remitting Multiple Sclerosis: Analysis of Placebo Data from Four Randomized Clinical Trials
Scott, Thomas, Wang, Ping, You, Xiaojun, Mann, Monica, Sperling, Bjørn
Published in Neuroepidemiology (01.03.2015)
Published in Neuroepidemiology (01.03.2015)
Get full text
Journal Article
Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
Weninger, Stacie, Sperling, Bjorn, Alexander, Robert, Ivarsson, Magnus, Menzies, Fiona M., Powchik, Peter, Weber, Christopher J., Altar, C. Anthony, Crystal, Ronald G., Haggarty, Stephen J., Loring, Jeanne, Bain, Lisa J., Carrillo, Maria C.
Published in Alzheimer's & dementia : translational research & clinical interventions (2020)
Published in Alzheimer's & dementia : translational research & clinical interventions (2020)
Get full text
Journal Article
Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
Bloomgren, Gary, Sperling, Bjørn, Cushing, Kimberly, Wenten, Madé
Published in Therapeutics and clinical risk management (01.01.2012)
Published in Therapeutics and clinical risk management (01.01.2012)
Get full text
Journal Article
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
Diener, Hans‐Christoph, Marmura, Michael J., Tepper, Stewart J., Cowan, Robert, Starling, Amaal J., Diamond, Merle L., Hirman, Joe, Mehta, Lahar, Brevig, Thomas, Sperling, Bjørn, Cady, Roger
Published in Headache (01.01.2021)
Published in Headache (01.01.2021)
Get full text
Journal Article
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
Ailani, Jessica, McAllister, Peter, Winner, Paul K, Chakhava, George, Krog Josiassen, Mette, Lindsten, Annika, Sperling, Bjørn, Ettrup, Anders, Cady, Roger
Published in BMC neurology (03.06.2022)
Published in BMC neurology (03.06.2022)
Get full text
Journal Article
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Published in Journal of headache and pain (30.03.2021)
Published in Journal of headache and pain (30.03.2021)
Get full text
Journal Article
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study
Barbanti, Piero, Goadsby, Peter J., Lambru, Giorgio, Ettrup, Anders, Christoffersen, Cecilie Laurberg, Josiassen, Mette Krog, Phul, Ravinder, Sperling, Bjørn
Published in Journal of headache and pain (02.12.2022)
Published in Journal of headache and pain (02.12.2022)
Get full text
Journal Article
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trial
Ashina, Messoud, Tepper, Stewart J., Gendolla, Astrid, Sperling, Bjørn, Ettrup, Anders, Josiassen, Mette Krog, Starling, Amaal J.
Published in Journal of headache and pain (20.11.2023)
Published in Journal of headache and pain (20.11.2023)
Get full text
Journal Article
Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil
Get full text
Conference Proceeding
Journal Article
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER Study
Pozo-Rosich, Patricia, Ashina, Messoud, Tepper, Stewart J., Jensen, Sidsel, Boserup, Line Pickering, Josiassen, Mette Krog, Sperling, Bjørn
Published in Neurology and therapy (01.04.2024)
Published in Neurology and therapy (01.04.2024)
Get full text
Journal Article
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial
Ailani, Jessica, McAllister, Peter, Winner, Paul K, Chakhava, George, Josiassen, Mette Krog, Lindsten, Annika, Sperling, Bjarn, Ettrup, Anders, Cady, Roger
Published in BMC neurology (06.09.2023)
Published in BMC neurology (06.09.2023)
Get full text
Journal Article
Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Published in Journal of headache and pain (25.05.2021)
Published in Journal of headache and pain (25.05.2021)
Get full text
Journal Article
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
Ravnborg, Mads, MD, Sørensen, Per Soelberg, Prof, Andersson, Magnus, MD, Celius, Elisabeth G, MD, Jongen, Peter J, MD, Elovaara, Irina, MD, Bartholomé, Emmanuel, MD, Constantinescu, Cris S, MD, Beer, Karsten, MD, Garde, Ellen, MD, Sperling, Bjørn, MD
Published in Lancet neurology (01.07.2010)
Published in Lancet neurology (01.07.2010)
Get full text
Journal Article
Patients transitioning from non-pegylated to pegylated interferon beta-1a have a low risk of new flu-like symptoms: ALLOW phase 3b trial results
Naismith, Robert T, Hendin, Barry, Wray, Sibyl, Huang, DeRen, Gaudenzi, Fiorenza, Dong, Qunming, Sperling, Bjørn, Mann, Monica, Werneburg, Brian
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2019)
Published in Multiple sclerosis journal - experimental, translational and clinical (01.01.2019)
Get full text
Journal Article